The impact of the COVID-19 Pandemic on hypertension phenotypes (ESH ABPM COVID-19 study)
European Journal of Internal Medicine · 2025
DOI: 10.1016/j.ejim.2024.08.027 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Internal Medicine, 2025. Verfasst von Aleksandra Ostrowska und 16 weiteren Autor:innen. Beteiligte Einrichtung: 1st Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Jagiellonian University Medical College, Krakow, Poland. Hauptthemen laut MEDLINE: COVID-19, Hypertension, Blood Pressure Monitoring, Ambulatory, Phenotype. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Office of Environment, Safety, and Health.
Abstract (Originalsprache)
OBJECTIVE: The COVID-19 pandemic had a major impact on medical care. This study evaluated the influence of the pandemic on blood pressure (BP) control and hypertension phenotypes as assessed by office and 24-hour ambulatory BP monitoring (ABPM). DESIGN AND METHODS: Data were collected from 33 centers including Excellence Centers of the European Society of Hypertension. Two groups of patients with treated hypertension were compared. Pandemic group: including participants who had ABPM twice - at visit 2 during the COVID-19 pandemic and visit 1 performed 9-15 months prior to visit 2. Pre-pandemic group: had ABPM at two visits, performed before the pandemic within 9-15 months interval. We determined the following hypertension phenotypes: masked hypertension, white coat hypertension, sustained controlled hypertension (SCH) and sustained uncontrolled hypertension (SUCH). We analyzed the prevalence of phenotypes and their changes between visits. RESULTS: Data of 1419 patients, 616 (43 %) in the pandemic group and 803 (57 %) in the pre-pandemic group, were analyzed. At baseline (visit 1), the prevalence of hypertension phenotypes did not differ between groups. In the pandemic group, the change in hypertension phenotypes between two visits was not significant (p = 0.08). In contrast, in the pre-pandemic group, the prevalence of SCH increased during follow-up (28.8 % vs 38.4 %, p < 0.01) while the prevalence of SUCH decreased (34.2 % vs 27.8 %, p < 0.01). In multivariable adjusted analysis, the only factor influencing negative changes of hypertension phenotypes was the COVID-19 pandemic period. CONCLUSION: These results indicate a negative impact of the COVID-19 pandemic on BP control assessed by hypertension phenotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1st Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Jagiellonian University Medical College, Krakow, Poland.
- 1st Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Jagiellonian University Medical College, Krakow, Poland. Electronic address: wiktoria.wojciechowska@uj.edu.pl.
- Cardiology Department Klinikum Wels-Grieskirchen, Wels, Austria.
- Hypertension Clinic, Hadassah-Hebrew University Medical Center, Mount Scopus, Jerusalem, and Faculty of Medicine, Hadassah-Hebrew University, School of Medicine, Jerusalem, Israel.
- Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique and Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
- Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece.
Förderung
- Office of Environment, Safety, and Health
Zitieren
APA
Ostrowska, A., Wojciechowska, W., Rajzer, M., Weber, T., Bursztyn, M., Persu, A., Stergiou, G., Kiełbasa, G., Chrostowska, M., Doumas, M., Parati, G., Bilo, G., Grassi, G., Mancia, G., Januszewicz, A., Kreutz, R., & ESH ABPM COVID-19 Study Investigators (2025). The impact of the COVID-19 Pandemic on hypertension phenotypes (ESH ABPM COVID-19 study). European Journal of Internal Medicine. https://doi.org/10.1016/j.ejim.2024.08.027
Vancouver
Ostrowska A, Wojciechowska W, Rajzer M, Weber T, Bursztyn M, Persu A, et al. The impact of the COVID-19 Pandemic on hypertension phenotypes (ESH ABPM COVID-19 study). European Journal of Internal Medicine. 2025. doi:10.1016/j.ejim.2024.08.027
BibTeX
@article{Ostrowska2025,
author = {Ostrowska, Aleksandra and Wojciechowska, Wiktoria and Rajzer, Marek and Weber, Thomas and Bursztyn, Michael and Persu, Alexandre and Stergiou, George and Kiełbasa, Grzegorz and Chrostowska, Marzena and Doumas, Michaelis and Parati, Gianfranco and Bilo, Grzegorz and Grassi, Guido and Mancia, Giuseppe and Januszewicz, Andrzej and Kreutz, Reinhold and ESH ABPM COVID-19 Study Investigators, ESH ABPM COVID-19 Study Investigators},
title = {The impact of the COVID-19 Pandemic on hypertension phenotypes (ESH ABPM COVID-19 study)},
journal = {European Journal of Internal Medicine},
year = {2025},
doi = {10.1016/j.ejim.2024.08.027}
}
EUVIMED